4//SEC Filing
HOMCY CHARLES J 4
Accession 0000950170-25-107510
CIK 0001743881other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 7:06 PM ET
Size
19.3 KB
Accession
0000950170-25-107510
Insider Transaction Report
Form 4
HOMCY CHARLES J
Director
Transactions
- Sale
Common Stock
2025-08-08$46.64/sh−58,338$2,720,849→ 966,674 total - Sale
Common Stock
2025-08-08$45.87/sh−191,662$8,791,593→ 1,025,012 total - Sale
Common Stock
2025-08-11$48.00/sh−50,000$2,400,000→ 916,674 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 8, 2025.
- [F2]Represents the weighted average sale price of the shares sold from $45.395 to $46.38 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F3]Represents the weighted average sale price of the shares sold from $46.40 to $46.84 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001192591
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 7:06 PM ET
- Size
- 19.3 KB